Gore, I., and Burrows, S.: A reconsideration of the pathogenesis of Buerger's disease. Am. J. Clin. Path., 29: 319, 1958.
3.
Wessler, S., Ming, S., Gurewich, V., and Freiman, D.G.: A critical evaluation of thromboangiitis obliterans. The case against Buerger's disease. New England J. Med., 262: 1149,1960 .
Barker, N.W.: The case for retention of the diagnostic category "thromboangiitis obliterans ." Circulation, 25: 1, 1962.
6.
McKusick, V.A. : Buerger's disease: A distinct clinical and pathologic entity. J. A. M. A., 181: 5, 1962.
7.
Abramson, D.I. : Thromboangiitis obliterans: A true clinical entity. Am. J. Cardiol., 12: 107, 1963.
8.
Lempert, H.: Method quoted by H. Varley in Practical Clinical Biochemistry, 3. Ed., p. 191. Heineman, London, 1962.
9.
Smith, R.T.: A heparin-precipitable fraction of human plasma. II. Occurrence and significance of the fraction in normal individuals and in various disease states. J. Clin. Invest., 36: 605, 1957.
10.
Cotton, R.C. , and Wade, E.G.: Effect of sudden withdrawal of long-term anticoagulant therapy on heparin resistance and plasma fibrinogen level. Clin. Sci., 26: 337, 1963.
11.
Buckell, M. : The effect of citrate on euglobulin methods of estimating fibrinolytic activity. J. Clin. Path.,11: 403, 1958.
12.
Connerty, H.V. , Briggs, A.R., and Eaton, E.H.: Simplified determination of the lipid components of blood serum. Clin. Chem., 7: 37, 1961.
13.
Barrett, A.M. : Adventitious factors affecting the concentration of free fatty acids in the plasma of rats. Brit. J. Pharmacol. , 22: 577, 1964.
14.
Dole, V.P.: A relation between non-esterified fatty acids in plasma and the metabolism of glucose. J. Clin. Invest., 35: 150, 1956.
15.
Stone, M.C. , and Thorp, J.M.: A new technique for the investigation of the low-density lipoproteins in health and disease. Clin. Chim. Acta, 14: 812, 1966.
16.
Westergren, A.: Studies of the suspension stability of the blood in pulmonary tuberculosis. Acta med. scand.,54: 247, 1921.
17.
Kurien, V.A. , and Oliver, M.F.: Serum free fatty acids after acute myocardial infarction and cerebral vascular occlusion. Lancet, 2: 122, 1966.
18.
Sweet, B., Rifkind, B.M., and McNichol, G.P.: The relationship between blood lipids and the fibrinolytic enzyme system. J. Atheroscler. Res.,6: 359, 1966.
19.
Smith, R.T. , and von Korff, R.W.: A heparin-precipitable fraction of human plasma. I. Isolation and characterization of the fraction. J. Clin. Invest., 36: 596, 1957.
20.
Shainoff, J.R. , and Page, I.H.: Cofibrins and fibrin-intermediates as indicators of thrombin activity in vivo. Circulation Res., 8: 1013, 1960.
21.
Godal, H.C. : Quantitative and qualitative changes in fibrinogen following major surgical operations. Acta med. scand.,171: 687, 1962.
22.
Thomas, L., Smith, R.T., and von Korff, R.: Studies on the generalized Shwartzman reaction. VII. The role of fibrinogen in the deposition of fibrinoid after combined injections of endotoxin and synthetic acidic polymer. J. Exper. Med., 102: 263, 1955 .
23.
Lee, L.: Reticulo endothelial clearance of circulating fibrin in the pathogenesis of the generalized Shwartzman reaction. J. Exper. Med., 115: 1065, 1962.
24.
De Takats, G.: Heparin tolerance test of clotting mechanism . Surg. Gynec. & Obst.,77: 31, 1943.
25.
Hagedorn, A.B. , and Barker, N.W.: Response of persons with and without intravascular thrombosis to heparin tolerance test. Am. Heart J., 35: 603, 1948.
26.
Naide, M.: Causative relationship of dermatophytosis to thromboangiitis obliterans. Am. J. M. Sc.,202: 822, 1941.
27.
Marples, M.J. : Ecology of Human Skin, p. 479. Charles C Thomas, Springfield, Ill., 1965.
28.
Singh, N.: Femoral arteriography in peripheral vascular disorders of the lower limbs . M.S. Thesis, University of Lucknow, 1958.